Deforolimus Trial 106-A Phase I Trial Evaluating 7 Regimes of Oral Deforolimus (AP23573, MK-8669)

Reviewer: Eric Shinohara MD, MSCI
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 31 de mayo del 2008

Translation for this article does not exist


Click on any of these terms for more related articles